Last reviewed · How we verify

NCT06368843

the Impact of Ketamine Gargling on the Incidence of Post Intubation Sore Throat

Not yet recruiting Last updated 16 April 2024
What this trial tests

trial testing Gargle with ketamine in Postoperative Sore Throat in 80 participants. Not yet recruiting.

Timeline
25 April 2024
Primary endpoint
15 August 2024
20 September 2024

Quick facts

Lead sponsorAl-Azhar University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment80
Start date25 April 2024
Primary completion15 August 2024
Estimated completion20 September 2024
Sites1 location across Iraq

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

Adults 18 to 45, any sex, with Postoperative Sore Throat. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Tracheal intubation often causes trauma to the airway mucosa, leading to postoperative sore throat (POST), which has been reported to occur in 21-65% of cases. While considered a minor complication, POST can contribute to postoperative discomfort and patient dissatisfaction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postoperative Sore Throat

Currently open trials in the same condition.

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06368843.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing